Related Experiment Videos
The initiation of fetal hemoglobin biosynthesis
Biochimica Et Biophysica Acta
|October 25, 1979
Summary
Human fetal hemoglobin delta chain biosynthesis begins with methionine removal. This process, studied in placental blood reticulocytes, involves approximately 40-60 amino acid residues before N-terminal methionine is cleaved.
Area of Science:
- Molecular Biology
- Biochemistry
- Hematology
Background:
- Hemoglobin biosynthesis involves initiation with methionine, which is later removed.
- Understanding the initiation of fetal hemoglobin (HbF) delta chain synthesis is crucial for studying hemoglobinopathies.
Purpose of the Study:
- To investigate the initiation of human fetal hemoglobin delta chain biosynthesis.
- To determine the stage of N-terminal methionine removal during delta chain elongation.
Main Methods:
- Utilized fresh placental blood for radioactive amino acid labeling experiments.
- Isolated nascent peptide chains from the polysomal fraction of reticulocytes.
- Analyzed labeled tryptic peptides to estimate peptide chain length.
Main Results:
- Established that human fetal hemoglobin delta chain biosynthesis is initiated with a methionyl residue.
- Quantified the number of amino acid residues in the nascent gamma chain at the time of N-terminal methionine removal (40-60 residues).
Conclusions:
- The N-terminal methionine is removed from the human fetal hemoglobin delta chain during peptide elongation.
- This removal occurs when the nascent gamma chain comprises 40-60 amino acid residues.